Brain amyloid imaging--FDA approval of florbetapir F18 injection.

N Engl J Med

Division of Medical Imaging Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.

Published: September 2012

Download full-text PDF	Source
http://dx.doi.org/10.1056/NEJMp1208061	DOI Listing

Publication Analysis

brain amyloid

amyloid imaging--fda

imaging--fda approval

approval florbetapir

florbetapir f18

f18 injection

brain

imaging--fda

approval

florbetapir

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!